Lai-Ming Ching
6Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Jan 14, 2003 → Oct 15, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7510830B2 | Cancer treatment by combination therapy | Human Necessities | 109 | Expired |
| US7462642B2 | Anti-cancer combinations | Human Necessities | 109 | Expired |
| US7585893B2 | Anti-cancer composition comprising DMXAA or related compound | Human Necessities | 109 | Expired |
| US10888567B2 | Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy | Chemistry; Metallurgy | 1 | Active |
| US11826316B2 | Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy | Chemistry; Metallurgy | 0 | Active |
| US11414428B2 | Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.